XTL BIOPHARMACEUTICALS LTD. Derivative Financial Liabilities
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Derivative Financial Liabilities of $22.00 thousand as of 2022-06-30, per its 6-K filed 2022-08-24.
Discontinued › Notes
ifrs-full:DerivativeFinancialLiabilities · last filed 2022-08-24
- 2022-06-30: Derivative Financial Liabilities $22.00K.
- 2021-12-31: Derivative Financial Liabilities $1.05M.
- 2021-06-30: Derivative Financial Liabilities $3.41M.
- 2020-12-31: Derivative Financial Liabilities $2.64M.
| Period end | Derivative Financial Liabilities |
|---|---|
| 2022-06-30 | $22.00K 6-K · filed 2022-08-24 |
| 2021-12-31 | $1.05M 6-K · filed 2022-08-24 |
| 2021-06-30 | $3.41M 6-K · filed 2022-08-24 |
| 2020-12-31 | $2.64M 6-K · filed 2022-08-24 |